Atreca Inc (FRA:0C1)
€ 0.0435 -0.0715 (-62.17%) Market Cap: 2.93 Mil Enterprise Value: -15.66 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Atreca Inc Turning the Current Cancer Therapeutic Discovery Paradigm on its Head Transcript

Feb 21, 2021 / NTS GMT
Neal Howard
Health Professional Radio - Moderator

Hello and welcome to Health Professional Radio. I'm your host, Neal Howard. Thanks for joining us, again. Going to be speaking with Mr. John Orwin this evening, President and CEO of Atreca. It's a biopharmaceutical company. He is joining us to talk about their drug discovery platform and how they're thinking a bit differently about the fight against cancer. Welcome to Health Profession Radio, Mr. John Orwin. Thanks for taking the time.

John Orwin
Atreca, In. - President & CEO

Thank you for having me, Neal.

Questions & Answers

Neal Howard
Health Professional Radio - Moderator

You are CEO of Atreca, what's your professional background and what is your role there at Atreca? What's your vision there?

John Orwin
Atreca, In. - President & CEO

Sure. I have a little over 30 years of experience in the pharmaceutical and biotech industry. My role as President and Chief Executive Officer of Atreca, I joined a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot